Michael Kauffman, Chief Executive Officer at Karyopharm Therapeutics Inc. (KPTI), sold 17,634 shares at $16.48 ($291K) on 2020-02-19, disclosed to the SEC on 2020-02-21.
Open-market sale of $291k KPTI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.48 | 8,817 | $145K | 50.0% |
| 2 | $16.48 | 8,817 | $145K | 50.0% |
| Total | $16.48 avg | 17,634 | $291K | 100% |
| Filing → |
| KPTI | SELL | 2022-03-02 | $128K | — | Filing → |
| KPTI | SELL | 2022-02-22 | $440K | — | Filing → |
| KPTI | SELL | 2022-02-09 | $266K | — | Filing → |